Pervasive chromosomal instability and karyotype order in tumour evolution

Journal: Nature

Published: 2020-09-02

DOI: 10.1038/s41586-020-2698-6

Affiliations: 55

Authors: 55

Go to article
Institutions Share
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.16
UCL Cancer Institute, United Kingdom (UK) 0.06
Department of Molecular Medicine (MOMA), AU, Denmark 0.06
Cancer Genomics Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.05
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK) 0.05
Bioinformatics and Biostatistics Platform, The Francis Crick Institute, United Kingdom (UK) 0.04
Wellcome Sanger Institute, United Kingdom (UK) 0.03
Cancer Dynamics Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.03
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.03
Berlin Institute for Medical Systems Biology (BIMSB), MDC, Germany 0.02
UCSF Department of Dermatology, United States of America (USA) 0.02
Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.02
Research Division, Peter Mac, Australia 0.02
The University of Melbourne (UniMelb), Australia 0.02
Institute Gustave-Roussy (IGR), France 0.02
Laboratory for Cell Biology and Genetics, The Rockefeller University, United States of America (USA) 0.02
MRC Institute of Genetics and Molecular Medicine (IGMM), United Kingdom (UK) 0.02
School for Oncology and Developmental Biology (GROW), Maastricht UMC+, Netherlands 0.02
Division of Medical Oncology, NKI, Netherlands 0.02
Department of Mathematics, Dartmouth College, United States of America (USA) 0.02
Lund University Cancer Centre (LUCC), Sweden 0.02
Division of Oncology and Pathology, LU, Sweden 0.02
Stanford Cancer Institute (SCI), United States of America (USA) 0.02
University College Hospital (UCH), United Kingdom (UK) 0.02
UCL Bill Lyons Informatics Centre (BLIC), United Kingdom (UK) 0.01
Sir Peter MacCallum Department of Oncology, UniMelb, Australia 0.01
Department of Biomedicine Basel, Switzerland 0.01
Swiss Institute of Bioinformatics (SIB), Switzerland 0.01
Department of Human Genetics, KU Leuven, Belgium 0.01
Faculty of Medicine, AMU, France 0.01
Institut Paoli-Calmettes (IPC), France 0.01
Department of Radiation Oncology, MSKCC, United States of America (USA) 0.01
Computational Oncology Service, MSKCC, United States of America (USA) 0.01
Guy’s Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.01
Danish Cancer Society Research Center (DCRC), Denmark 0.01
Sanger Institute Experimental Cancer Genetics, United Kingdom (UK) 0.01
Computational Health Informatics Program (CHIP), BCH, United States of America (USA) 0.01
2nd Department of Pathology, SE, Hungary 0.01
UCL Genetics Institute (UGI), United Kingdom (UK) 0.01
DKTK Partner Site Berlin, Germany 0.01
Okinawa Institute of Science and Technology Graduate University (OIST), Japan 0.01
Department of Neurology, MGH, United States of America (USA) 0.01
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.01
UCSF Department of Pathology, United States of America (USA) 0.01
Oxford Big Data Institute (BDI), United Kingdom (UK) 0.01
Department of Medicine, MGH, United States of America (USA) 0.01
Broad Institute of MIT and Harvard, United States of America (USA) 0.01
Bioinformatics Research Centre (BiRC), AU, Denmark 0.01
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.01
Faculté de Médicine, Université Paris Saclay, France 0
Department of Medical Oncology, IGR, France 0
Laboratoire Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM), France 0
Predictive Biomarkers and Novel Therapeutic Strategies in Oncology, France 0

Return